Alliance A032002 (ART): Phase II randomized trial of atezolizumab versus atezolizumab and radiation therapy for platinum ineligible/refractory metastatic urothelial cancer
- Citation:
- J Clin Oncol vol 41 (6) TPS589 Journal of Clinical Onc
- Meeting Instance:
- ASCO GU 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Himanshu Nagar Karla Ballman Scott T. Tagawa Alan Tan Bishoy M. Faltas Arshin Sheybani Shiva Baghaie Lawrence H. Schwartz David Kozono Jeffrey Bogart Olivia Conway Gina Mazza Ronald Chen Andrew Lacetti Jonathan Rosenberg Michael J. Morris
- Networks:
- IWORC, KANSAS, LAPS-MA036, LAPS-NY016, NY018, NY141
- Study
- Alliance-A032002
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: